Are you the publisher? Claim or contact us about this channel

Embed this content in your HTML


Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog

Channel Description:

Critical analysis of scholarly open-access publishing

older | 1 | .... | 479 | 480 | (Page 481) | 482 | 483 | .... | 541 | newer

    0 0

    I have had an excellent experience with this journal (Mathematical Problems in Engineering). Two good reviews. One accepted it, the other was more skeptical. The editor allowed us to answer and finally we convinced the skeptical reviewer. The proofing was very good.
    Actually I was going to send the manuscript to a Springer journal but since I received the waive cost, I tried here.
    We are slaves of IF, and I tell you that I received ridiculous reviews (and sometimes just 1 review) from journals in the top 10% of the IF. Some of these papers were thereafter accepted in other top 10% journals.
    There are journals in Q2 much, much better than many in Q1.

    0 0

    Can you check the validity of papers?

    0 0

    Dear Dr. Beall,

    I have seen recently that Journal – “Sustainability” from MDPI, has an increasing impact factor, from ISI / T.Reuters.

    How is this possible that being indexed with impact factor and still on this predatory list?

    Shall I send my manuscript there or no?


    Danniel Brennar (Ph.D. student)

    0 0

    My experience with poor quality images – my own, that is – is that these are rarely identified up front. If problems arise, this is either at review or by production staff, particularly the latter, irrespective which journal is concerned.

    0 0

    I see that Virtus no longer appears in the publisher list? Is there a reason for this?


    0 0

    Thanks for this Information! I just received a request from this organization. They still seem to be active.

    0 0

    I removed MDPI from my list in October, 2015.
    There are some publishers whose journals have impact factors that are on my list. The metric is not necessarily a mark of quality.
    Although MDPI is not on my list, I would encourage you to seek a stronger publisher for your work.
    MDPI chiefly serves as a place to publish manuscripts that were rejected from stronger publishers.

    0 0

    Yes, I removed it from the list.

    0 0

    It’s published (or a clone of it may be published) by SciTechnol, which is on your list of publishers. I had a spam email from the journal today:

    Dear Dr. Keith Fraser,

    Greetings from La Prensa Medica!!

    It is my pleasure to introduce the 102 Years Old ISI and Elsevier Indexed Medical Journal – La Prensa Medica led by scientists (Editorial Board) from all over the world for publication of works related to all the Sub Specialities of Medical Sciences.

    We have seen your research profile and publications adding valuable knowledge to the existing scientific literature and strongly believe that your papers will attract the readers of the journal and so cordially invite you to contribute papers for the journal’ s forthcoming issues.

    Indexing: Institute for Scientific Information (ISI) / Current contents, Thomson Reuters – BIOSIS – Thomson Scientific, SWETS information services, British Library, Elsevier Bibliographic Databases, Google Scholar.

    Journal Achievements

    ü Volume 102: Successfully completed 101 Years in publication world publishing scholarly papers from researchers all over the world.

    ü Rapid Publication: The articles receive a peer review decision within 14 days after submission and will be online in 7 days from acceptance.

    ü Editorial Manager System: Review process is carried out using Editorial Manager System maintaining quality peer review.

    ü Regular Issues: Regular Bimonthly issues are released and the frequency of the journal is maintained.

    E-mail to: editor.lpma@scitechnol.org and editor.lpma@scitechnol.com Submission Deadline: September 30th, 2016

    I wish you all success for your ongoing research works and future endeavors. Feel free to contact us for any further details.

    Thanks & Best Regards,
    Muntha P
    Journal Coordinator
    La Prensa Medica

    0 0

    This publisher is not on my list. I don’t know about your publication.

    0 0

    I need your comments on this journal. Is this journal having any worth to publish my research article.

    Journal of Business Studies Quarterly (JBSQ).


    Ghulam Muhammad

    0 0

    Dear Will,

    I did not understand well did Symbiosis group is good predatory?

    Our doc received an aemail from
    “Journal of Endocrinology and Diabetes”

    Dear Dr. ………………,

    Greetings from Symbiosis Group!

    We are glad to share with you that Journal of Endocrinology and Diabetes is indexed in Citefactor; DRJI; and also allowed to submit all the quality and NIH funded articles to PubMed.

    0 0

    No, this journal is unworthy. It's on my <a href="https://scholarlyoa.com/individual-journals/" target="_blank">list</a>. I recommend you find a better journal.

    0 0

    Hello Everyone, does anyone know anything about Womens’ Health and Gynecology? It is under the organization “Scient Open Access”.


    I think I have been scammed. They accepted my manuscript quite quickly. It says they’re located in Canada but always emailed me at 1-3 am EST/my time. They’ve dropped off the earth at this point and I’ve been waiting to hear back from them as I have sent them my corrected galley proof a week ago.

    Can someone please confirm for me of this is a scam? I noted after I submitted that there’s a publication fee of 700$

    0 0

    Please check on these publisher for me, edorium journals .

    0 0

    Dear Jefrey please go to Oriental Journal of chemistry, this is facking to

    0 0

    The publisher Scient Open Access is included on my list <a href="https://scholarlyoa.com/publishers/" target="_blank">here</a>. I strongly recommend researchers avoid all journals from this publisher.

    0 0

    I have got the same email today
    Thank you for already having included KEI Journals on your list.

    “Dear Dr. Luttenberger,
    My last email must have reached you at a bad time so I am following up. If you are not the right person to talk to about this please let me know or feel free to forward this email.
    Here a links to a couple papers on PubMed published by the Medical Research Archives, so you may get a sense of the style and formatting.
    Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: The Rationale for Combination Therapies.
    Kinomic Alterations in Atypical Meningioma.

    Dr. Kateryna Bielka

    From: Dr. Kateryna Bielka, M.D.
    Date: 2016-09-16 13:28:26.346
    To: “Dr. Luttenberger”
    Subject: Followup to Dr. Luttenberger’s article?
    Dear Dr. Luttenberger,
    I hope this email finds you well. My colleague asked if I could get in touch with you about a paper you authored entitled “From board to bedside – training the communication competences of medical students with role plays”. Firstly, thank you for taking the time to publish this, it was an interesting read. I am hoping to discuss with you having a short follow-up article or perhaps a review article published in one of the next issues of the Medical Research Archives. I think our readers would be interested in a paper with information from any continued research or new data since this was published. It would not have to be a long article, but if you don’t have time for this perhaps you could ask one of your co-authors or students to collaborate or contribute instead.
    If you have moved on from your previous research interests I am certainly interested in knowing more about your current projects; perhaps there is the potential for an article that would be published in our journal. If you have any questions about whether or not a certain subject fits our scope I can put you in contact with Dr. Steven Lindheim from our editorial board.
    Could you please let me know your thoughts on this?

    Dr. Kateryna Bielka, M. D.
    Senior Editor
    Medical Research Archives

    0 0

    I was very proud to be invited as guest editor of lead because of my reputation …. I thought . ; (

    0 0

    Hello good morning
    What about this journal?
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy [DMSO]
    Thank you in advance

older | 1 | .... | 479 | 480 | (Page 481) | 482 | 483 | .... | 541 | newer